Effects of endoscopic treatment of acute upper gastrointestinal bleeding at different times and its influences on hemostasis time,rebleeding rate and SF-36 score
Objective To explore the effects of endoscopic treatment of acute upper gastrointestinal bleeding(AUGIB)at different times and its influences on hemostasis time,rebleeding rate and the MOS Item Short From Health Survey(SF-36)score.Methods A total of 100 patients with AUGIB admitted from January 2020 to October 2021 were selected as the research objects.According to the different admission time,the patients were divided into group A(25 cases,admission endoscopic treatment≤6 h),group B(25 cases,admission endoscopic treatment>6-12 h),group C(25 cases,admission endoscopic treatment>12-24 h)and group D(25 cases,admission endoscopic treatment>24-48 h).The hemostasis time,rebleeding rate and SF-36 score of the four groups were compared.Results The hemostasis time of the group A was the shortest;there was statistically significant difference in the hemostatic time of the four groups(P<0.05).The rebleeding rate of the group B was the highest,followed by the group C and the group D;there was statistically significant difference in the rebleeding rate of the four groups(P<0.05).After treatment,the SF-36 score of the four groups increased,and that in the group A was higher than the group B,the group C and the group D,and the difference was statistically significant(P<0.05).Conclusion The timely admission of patients with AUGIB to endoscopic treatment within 6 h after the onset of the disease can shorten the hemostasis time,reduce the rebleeding rate,improve the SF-36 score,and reduce the damage of the upper digestive tract,which is worthy of recommendation.
acute upper gastrointestinal bleedingendoscopictreatment timehemostatic effectthe MOS Item Short From Health Survey score
万方数据
维普
